2017 Summit – Michael C. Heinrich

Management of Imatinib-Resistant GIST

MICHAEL C. HEINRICH: Dr. Heinrich is Professor of Medicine and Cell and Developmental Biology at OHSU Knight Cancer Institute. He also is head of the OHSU Knight Cancer Institute GIST Translational and Clinical Research Programs. He earned his MD in 1984 from Johns Hopkins School of Medicine, completing both his residency training and Hematology and Medical Oncology fellowship at OHSU. His primary research interest is development of novel TKIs for treatment of human cancers, including both pre-clinical identification of novel molecular targets and testing of new agents in the lab and clinic. (www.heinrich-corless.net) Dr. Heinrich will share with us his presentation: “Management of Imatinib-Resistant GIST.”

This presentation was made Saturday September 16th, 2017 at the GIST Information Support and Therapy Summit (GISTS) organized by GIST Support International at MD Anderson Cancer Center.

For additional presentations at GISTS, click here.

Novartis   Pfizer Oncology   Bayer   Ignyta   blueprint   Deciphera